CDK1 and neoplasm: A study found that in renal cell carcinoma, the down-regulation of Aurora A kinase induces a decrease in the expression of cyclin B1/CDK1 complex, and inhibits cell proliferation and metastasis by blocking ERK activity, thereby exerting anti-tumor effects [97].